Researchers who used AI to analyze hundreds of thousands of social media posts say they have identified unreported GLP-1 side ...
PHILADELPHIA - A new study from the University of Pennsylvania suggests that artificial intelligence may help identify ...
An AI study analyzing more than 400,000 Reddit posts identified patient-reported symptoms associated with GLP-1 medications ...
By using AI to analyze more than 400,000 Reddit posts, Penn researchers have identified patient-reported symptoms associated ...
A 2026 program overview covering how Vital Step structures its doctor-prescribed compounded semaglutide and tirzepatide ...
Jelly Lean is drawing increased consumer interest as counterfeit and misrepresented listings continue appearing across online ...
Q4 FY2025 earnings call highlights: comps +0.7%, EBITDA $903M, FY26 EPS/EBITDA outlook, IRA pharmacy headwinds & buybacks—read now.
FormBlends' platform extends beyond GLP-1 receptor agonists into the broader peptide therapy landscape, which reached $140.86 ...
FormBlends' platform extends beyond GLP-1 receptor agonists into the broader peptide therapy landscape, which reached $140.86 billion globally in 2025 and is projected to grow to $260.25 billion by ...
A 2026 informational overview of GLPro's blood sugar support formula, Berberine HCL and GLP-1 research context, bariatric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results